Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 23 Apr 2024

Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression

in Thoracic Oncology

Huimin Zhang
Xiaofeng Cong
Jiaxin Yin
Chen Chen
Ziling Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1387388

2,651 views

Case Report

Published on 22 Apr 2024

Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review

in Thoracic Oncology

Wenjuan Zhong
Longqiu Wu
Lixing Huang
Jianfeng Wang
Huaqiu Shi
Shugui Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1377451

4,868 views
6 citations

Original Research

Published on 22 Apr 2024

TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations

in Thoracic Oncology

Armin Frille
Myriam Boeschen
Hubert Wirtz
Mathias Stiller
Hendrik Bläker
Maximilian von Laffert

Frontiers in Oncology

doi 10.3389/fonc.2024.1357583

3,326 views
10 citations

Case Report

Published on 19 Apr 2024

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

in Thoracic Oncology

Siyuan Huang
Linlin Li
Ningning Yan
Huixian Zhang
Qianqian Guo
Sanxing Guo
Di Geng
Xincheng Liu
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331387

2,623 views
3 citations

Editorial

Published on 19 Apr 2024

Editorial: Updates on combination therapy for lung cancer volume II

in Thoracic Oncology

Alberto Pavan
Liyun Shi
Muhammad Abbas

Frontiers in Oncology

doi 10.3389/fonc.2024.1393278

1,288 views

Case Report

Published on 18 Apr 2024

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report

in Thoracic Oncology

Dan Li
Yue Zhu
Jincheng Song
Dafu Yang
Saiqiong Cui
Xin Liu
Le Wang
Jiangyan Zhang
Evenki Pan
Zhaoxia Dai

Frontiers in Oncology

doi 10.3389/fonc.2024.1339511

2,568 views
1 citation

Original Research

Published on 18 Apr 2024

Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors

in Thoracic Oncology

Balazs Halmos
Pragya Rai
Jae Min
Xiaohan Hu
Diana Chirovsky
Mark Shamoun
Bin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1285280

3,448 views
5 citations

Systematic Review

Published on 17 Apr 2024

Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis

in Thoracic Oncology

Yuxuan Cao
Xinbo Liu
Jiayi Liu
Ziyi Su
Wenxuan Liu
Lei Yang
Liwen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1357248

3,123 views
6 citations

Case Report

Published on 16 Apr 2024

Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion

in Thoracic Oncology

Su-Su Dong
Wen Dong
Ya-Fen Tan
Qiang Xiao
Tian-Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1370901

2,074 views
2 citations

Systematic Review

Published on 16 Apr 2024

Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)

in Thoracic Oncology

Wen Zhong
Xiaofei Zhao
Xiabiao Zhang
Yiwen Xu
Mengqian Liu
Xiaoyun Yang
Yi Jiang
Xiaozhu Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1358101

5,568 views
6 citations

Case Report

Published on 15 Apr 2024

Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report

in Thoracic Oncology

Eleonora Faccioli
Federica Grosso
Andrea Dell’Amore
Sara Delfanti
Giovanni Zambello
Luigi Cerbone
Gianluca Canu
Antonina De Angelis
Viola Sambataro
Federica Pezzuto

Frontiers in Oncology

doi 10.3389/fonc.2024.1378530

1,746 views
1 citation

Original Research

Published on 12 Apr 2024

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma

in Thoracic Oncology

Ye Wang
Yingqiu Song
Runze Wang
Yu Wu
Mo Li
Ke Xu
Rong He
Zheng Wang
Qingqing Li
Feng-Ming (Spring) Kong

Frontiers in Oncology

doi 10.3389/fonc.2024.1265228

2,489 views
3 citations

Original Research

Published on 10 Apr 2024

A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer

in Thoracic Oncology

Thomas Jordan
Thitikorn Nuamek
Isabella Fornacon-Wood
Raffaele Califano
Joanna Coote
Margaret Harris
Hitesh Mistry
Paul Taylor
David Woolf
Corinne Faivre-Finn

Frontiers in Oncology

doi 10.3389/fonc.2024.1328871

2,654 views
5 citations

Brief Research Report

Published on 10 Apr 2024

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications

in Thoracic Oncology

Eziafa I. Oduah
Susan T. Sharfstein
Nagashree Seetharamu
Steven R. Grossman
Larisa Litovchick

Frontiers in Oncology

doi 10.3389/fonc.2024.1363543

2,297 views
1 citation

Case Report

Published on 09 Apr 2024

A case report of typical well-differentiated papillary mesothelial tumor diagnosed by internal thoracoscopy and literature review

in Thoracic Oncology

Jian Guo
XiaoHui Lv
Wei Zhang
Fang Dong
Lei Li
Juan Liu
Bing Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1359985

1,860 views

Original Research

Published on 08 Apr 2024

A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer

in Thoracic Oncology

Song Hu
Hao Ming
Qian He
Ming Ding
Hao Ding
Chong Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1314301

3,604 views
7 citations

Correction

Published on 08 Apr 2024

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

in Thoracic Oncology

Reem Altaf
Umair Ilyas
Anmei Ma
Meiqi Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1377858

1,022 views

Original Research

Published on 08 Apr 2024

Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial

in Thoracic Oncology

Da Zhao
Zhengguo Li
Xinli Hou
Lei Yang
Zeng Li
Li Yan
Hongling Li
Hua Liu
Xiaoping Liu
Feixue Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1335009

2,167 views
1 citation

Case Report

Published on 04 Apr 2024

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

in Thoracic Oncology

Changhong Dong
Chenxi Hu
Yanting Jiang
Kaiyuan Hui
Xiaodong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1368059

2,185 views
1 citation

Original Research

Published on 02 Apr 2024

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking

in Thoracic Oncology

Tian-Xiang Zhang
Xin-Chun Duan
Yong Cui
Ye Zhang
Meng Gu
Zi-Yu Wang
Wei-Ying Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1376502

2,384 views
6 citations

Case Report

Published on 02 Apr 2024

Uniportal video-assisted thoracoscopic segmentectomy for fetal adenocarcinoma lung cancer with severe pulmonary emphysema: a case report

in Thoracic Oncology

Yun-Sheng Wu
Yu-Ting Chen
Jen-Hao Chuang
Hsien-Chi Liao

Frontiers in Oncology

doi 10.3389/fonc.2024.1281211

1,532 views

Case Report

Published on 27 Mar 2024

Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review

in Thoracic Oncology

Raluca Lazar
Cathie Fischbach
Roland Schott
Laura Somme

Frontiers in Oncology

doi 10.3389/fonc.2024.1307882

3,871 views
6 citations

Original Research

Published on 27 Mar 2024

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)

in Thoracic Oncology

Alessandro Cafaro
Flavia Foca
Oriana Nanni
Marco Chiumente
Marina Coppola
Paolo Baldo
Sabrina Orzetti
Fiorenza Enrico
Vito Ladisa
Rosa Lerose

Frontiers in Oncology

doi 10.3389/fonc.2024.1351995

5,388 views
5 citations

Review

Published on 27 Mar 2024

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

in Thoracic Oncology

Madeleine B. Hopson
Sawsan Rashdan

Frontiers in Oncology

doi 10.3389/fonc.2024.1373388

3,909 views
1 citation

1,913 articles

articles

Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression

Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review

TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

Editorial: Updates on combination therapy for lung cancer volume II

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report

Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors

Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis

Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion

Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)

Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma

A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications

A case report of typical well-differentiated papillary mesothelial tumor diagnosed by internal thoracoscopy and literature review

A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking

Uniportal video-assisted thoracoscopic segmentectomy for fetal adenocarcinoma lung cancer with severe pulmonary emphysema: a case report

Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer